ChemoID assay

DIAGNOSTIC_TEST3 trials

Sponsors

Cordgenics, LLC

Conditions

Platinum-resistant Ovarian CancerRecurrent GlioblastomaRecurrent Ovarian CancerRecurrent Ovarian Carcinoma

Phase 3

Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma

CompletedNCT03632135

Cordgenics, LLCRecurrent Glioblastoma

Start: 2018-05-20End: 2023-12-31Updated: 2025-04-15

Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

WithdrawnNCT03632798

Cordgenics, LLCRecurrent Ovarian Cancer

Start: 2018-08-01End: 2019-06-10Updated: 2025-02-12

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Active, not recruitingNCT03949283

Cordgenics, LLCPlatinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma

Start: 2019-07-26End: 2024-12-30Target: 150Updated: 2024-08-22

Related Papers

ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial

npj Precision Oncology2025-03-252 citations

Relationship of cancer stem cell functional assay and objective response rate of patients with recurrent platinum-resistant ovarian cancer in a randomized trial.

Journal of Clinical Oncology2024-06-01

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial

Cell Reports Medicine2023-05-0138 citations

Abstract CT224: Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135)

Cancer Research2022-06-15

Multi-institutional randomized phase 3 trial comparing cancer stem cell-targeted versus physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135).

Journal of Clinical Oncology2022-06-012 citations

CTNI-34. INITIAL ANALYSIS OF PHASE-III TRIAL - STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY A CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135)

Neuro-Oncology2020-11-01

ACTR-47. PHASE-III TRIAL OF STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135)

Neuro-Oncology2019-11-01